Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Total Non-Current Liabilities

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Liabilities ₹144 Cr₹111 Cr₹108 Cr₹125 Cr₹159 Cr

What is the latest Total Non-Current Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Total Non-Current Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹144 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹144 Cr
Mar2025₹111 Cr
Mar2024₹108 Cr
Mar2023₹125 Cr
Mar2022₹159 Cr

How is Total Non-Current Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹144 Cr
29.59
Mar2025 ₹111 Cr
2.80
Mar2024 ₹108 Cr
-14.10
Mar2023 ₹125 Cr
-21.01
Mar2022 ₹159 Cr -

Compare Total Non-Current Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹44,980.8 Cr 5.2% 4.8% 5.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹452,707.0 Cr 1.4% 6.7% 12% Stock Analytics
DIVIS LABORATORIES ₹303,962.0 Cr 11.1% 23.5% 70% Stock Analytics
TORRENT PHARMACEUTICALS ₹179,494.0 Cr 1% 1.8% 34.3% Stock Analytics
DR REDDYS LABORATORIES ₹115,769.0 Cr 1.1% 11.8% 14.2% Stock Analytics
CIPLA ₹113,912.0 Cr 0.1% 6% -5.8% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

5.2%

4.8%

5.2%

SENSEX

3.3%

13.9%

-1.7%


You may also like the below Video Courses